2017
DOI: 10.1186/s12985-017-0838-x
|View full text |Cite
|
Sign up to set email alerts
|

Effective usage of cationic derivatives of polyprenols as carriers of DNA vaccines against influenza virus

Abstract: BackgroundCationic derivatives of polyprenols (trimethylpolyprenylammonium iodides – PTAI) with variable chain length between 6 and 15 isoprene units prepared from naturally occurring poly-cis-prenols were tested as DNA vaccine carriers in chickens and mice. This study aimed to investigate if PTAI could be used as an efficient carrier of a DNA vaccine.MethodsSeveral vaccine mixtures were prepared by combining different proportions of the vaccine plasmid (carrying cDNA encoding a vaccine antigen, hemagglutinin … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

2
8
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
6
1
1

Relationship

2
6

Authors

Journals

citations
Cited by 14 publications
(10 citation statements)
references
References 20 publications
2
8
0
Order By: Relevance
“…The compositions were stored at 4 °C up to 7 days. These compositions were previously shown to be effective DNA vaccine carriers (Stachyra et al 2017 ). They (and their use) are the subject of patents (No.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…The compositions were stored at 4 °C up to 7 days. These compositions were previously shown to be effective DNA vaccine carriers (Stachyra et al 2017 ). They (and their use) are the subject of patents (No.…”
Section: Methodsmentioning
confidence: 99%
“…They are involved in cell response to environmental stress, glycosylation, and prenylation of proteins, and also they intensify the fusion and increase the permeability of model membranes (Swiezewska and Danikiewicz 2005 ). Recent studies (Gawrys et al 2014b , 2018 ; Grecka et al 2016 ; Rak et al 2016 ; Stachyra et al 2017 ) show that cationic derivatives of polyisoprenoid alcohols, called PTAI, are non-toxic and may serve as lipofectants. In the present study, the effectiveness of two PTAI mixtures was investigated for plasmid DNA delivery into rats’ cells and to rats and compared to the commercially available reagents for transfection: in vivo-jetPEI® (Polyplus-transfection) and Avalanche®-in vivo Transfection Reagent (EZ Biosystems LLC).…”
Section: Introductionmentioning
confidence: 99%
“…Many DNA vaccine candidates for protecting chickens from avian influenza have been described [10,13,14], and one such vaccine has been licensed for use in the U.S. [15]. Protective DNA vaccine candidates were also designed and tested by our team [16][17][18][19][20].…”
Section: Introductionmentioning
confidence: 99%
“…(1) the potential to induce a broad immune response without the risks observed using replicating microorganisms [1] ; (2) the ability to simultaneously stimulate humoral and cellular immunity [2] ; (3) the process of purifying plasmid DNA is simple, inexpensive, and suitable for mass production [3] ; (4) DNA molecules are stable, therefore easy to transport and preserve [4] ; and (5) by simply mixing multiple plasmid DNA samples, antigens with similar biochemical properties can be combined to form a multivalent vaccine [5] . Based on these advantages, DNA vaccines may be substitutes for traditional vaccines and may have a wide range of applications in the treatment of infectious diseases in humans and animals [6] . For example, Zhang et al have developed a DNA vaccine for Clostridium di cile, which encodes two C. di cile toxin receptor binding domains and showed good results in mouse and hamster model experiments [7] .…”
Section: Introductionmentioning
confidence: 99%